During the past decade, Penn Prevention Unit conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Penn Prevention Unit" are "Lower Respiratory Tract Illness" (1 trials) and "Pre-Exposure Prophylaxis of HIV Infection" (1 trials). Many other conditions were trialed in "Penn Prevention Unit" in a lesser frequency.

Most popular intervention types in "Penn Prevention Unit" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "F/TAF (for US participants only)" (1 trials), "F/TDF" (1 trials), "Oral Lenacapavir (LEN)" (1 trials), "PTM F/TDF" (1 trials) and "PTM Oral LEN" (1 trials). Other intervention names were less common.

The vast majority of trials in "Penn Prevention Unit" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Penn Prevention Unit". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Penn Prevention Unit, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Penn Prevention Unit, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".